The use of sublingual buprenorphine-naloxone for reversing heroin overdose: A high-risk strategy that should not be recommended

Addiction

Volumn 103, Issue 12, 2008, Pages 2065-2066

  Nielsen, Suzanne ^a   Lintzeris, Nicholas ^b  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CENTRAL DEPRESSANT AGENT; DIAMORPHINE; OPIATE;

DRUG BINDING; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG OVERDOSE; DRUG TOLERANCE; FATALITY; HUMAN; LETTER; MORTALITY; RESPIRATION DEPRESSION; REVERSAL REACTION; SIDE EFFECT;

BUPRENORPHINE; DRUG COMBINATIONS; HEROIN; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OVERDOSE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 55649083764     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02385.x     Document Type: Letter

References (6)

1. ®). Addiction 2008 103 : 1226 8.
2. Boyd J., Randell T., Luurila H., Kuisina M. Serious overdoses involving buprenorphine in Helsinki. Acta Anaesthesiol Scand 2003 47 : 1031 3.
3. Gaulier J. M., Marguet P., Lacassie E., Dupuy J. L., Lachatre G. Fatal intoxication following self-administration of a massive dose of buprenorphine. J Forensic Sci 2000 45 : 226 8.
4. Pirnay S., Borron S. W., Giudicelli C. P., Tourneau J., Baud F. J., Ricordel I. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 2004 99 : 978 88.
5. Darke S., Zador D. Fatal heroin 'overdose': a review. Addiction 1996 91 : 1765 72.
6. Boas R. A., Villiger J. W. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 1985 57 : 192 6.